J. Mooney

发表

Monomeric Recombinant TCR Ligand Reduces Relapse Rate and Severity of Experimental Autoimmune Encephalomyelitis in SJL/J Mice through Cytokine Switch1

D. Bourdette, A. Vandenbark, H. Offner, 2004, The Journal of Immunology.

Recombinant TCR Ligand Induces Tolerance to Myelin Oligodendrocyte Glycoprotein 35-55 Peptide and Reverses Clinical and Histological Signs of Chronic Experimental Autoimmune Encephalomyelitis in HLA-DR2 Transgenic Mice1

L. Fugger, A. Vandenbark, H. Offner, 2003, The Journal of Immunology.

Evidence that the proposed novel human "neurokinin-4" receptor is pharmacologically similar to the human neurokinin-3 receptor but is not of human origin.

D. Y. Wang, H. Sarau, J. Foley, 2000, Molecular pharmacology.

Recombinant TCR Ligand Induces Early TCR Signaling and a Unique Pattern of Downstream Activation 1

A. Vandenbark, H. Offner, G. Burrows, 2003, The Journal of Immunology.

Downstream Activation TCR Signaling and a Unique Pattern of Recombinant TCR Ligand Induces Early

A. Vandenbark, H. Offner, G. Burrows, 2003 .

HLA-DRα1 Constructs Block CD74 Expression and MIF Effects in Experimental Autoimmune Encephalomyelitis

R. Bucala, Xiaolin Yu, A. Vandenbark, 2014, The Journal of Immunology.

HLA-DRa1 Constructs Block CD74 Expression and MIF Effects in Experimental Autoimmune Encephalomyelitis

R. Bucala, Xiaolin Yu, A. Vandenbark, 2014 .

This information is current as Autoimmune Encephalomyelitis Expression and MIF Effects in Experimental 1 Constructs Block CD 74 α HLA-DR

R. Bucala, Xiaolin Yu, A. Vandenbark, 2014 .

Rationally designed mutations convert complexes of human recombinant T cell receptor ligands into monomers that retain biological activity.

D. Bourdette, H. Bächinger, A. Vandenbark, 2005, Journal of chemical technology and biotechnology.

Single Chain Recombinant HLA-DQ2.5/peptide Molecules Block α2-gliadin-Specific Pathogenic CD4+ T Cell Proliferation and Attenuate Production of Inflammatory Cytokines: A Potential Therapy for Celiac Disease

A. Vandenbark, H. Offner, G. Burrows, 2010, Mucosal Immunology.

from Collagen-Induced Arthritis Receptor Ligands Protect DBA/1LacJ Mice MHC Class II Derived Recombinant T Cell

A. Vandenbark, G. Burrows, E. Rosloniec, 2013 .

MHC Class II Derived Recombinant T Cell Receptor Ligands Protect DBA/1LacJ Mice from Collagen-Induced Arthritis1

A. Vandenbark, H. Offner, S. Subramanian, 2008, The Journal of Immunology.

MHC Class II Derived Recombinant T Cell Receptor Ligands Protect DBA/1LacJ Mice from Collagen-Induced Arthritis

A. Vandenbark, G. Burrows, E. Rosloniec, 2007 .

A novel regulatory pathway for autoimmune disease: binding of partial MHC class II constructs to monocytes reduces CD74 expression and induces both specific and bystander T-cell tolerance.

Shayne F. Andrew, A. Vandenbark, H. Offner, 2013, Journal of Autoimmunity.

A Promising Therapeutic Approach for Treatment of Posterior Uveitis: Recombinant T Cell Receptor Ligand Protects Lewis Rats from Acute and Recurrent Experimental Autoimmune Uveitis

G. Adamus, G. Burrows, J. Mooney, 2010, Ophthalmic Research.